Prevention of breast cancer by recapitulation of pregnancy hormone levels

por Tonetti, Debra A
Publicado 2004

Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches

por Shete, Nivida, Calabrese, Jordan, Tonetti, Debra A.
Publicado 2023

PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients

por Tonetti, Debra A., Gao, Weihua, Escarzaga, Diana, Walters, Kelly, Szafran, April, Coon, John S.
Publicado 2012

Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer

por Perez White, Bethany, Molloy, Mary Ellen, Zhao, Huiping, Zhang, Yiyun, Tonetti, Debra A
Publicado 2013

Retraction Note to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer

por White, Bethany Perez, Molloy, Mary Ellen, Zhao, Huiping, Zhang, Yiyun, Tonetti, Debra A.
Publicado 2017

Protein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin

por Pham, Thao N. D., Perez White, Bethany E., Zhao, Huiping, Mortazavi, Fariborz, Tonetti, Debra A.
Publicado 2017

Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer

por Abderrahman, Balkees, Maximov, Philipp Y., Curpan, Ramona F., Hanspal, Jay S., Fan, Ping, Xiong, Rui, Tonetti, Debra A., Thatcher, Gregory R.J., Jordan, V. Craig
Publicado 2020

Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells

por Pal, Purab, Millner, Alec, Semina, Svetlana E., Huggins, Rosemary J., Running, Logan, Aga, Diana S., Tonetti, Debra A., Schiff, Rachel, Greene, Geoffrey L., Atilla-Gokcumen, G. Ekin, Frasor, Jonna
Publicado 2022

PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors

por Peng, Maoyu, Emmadi, Rajyasree, Wang, Zebin, Wiley, Elizabeth L., Gann, Peter H., Khan, Seema A., Banerji, Nilanjana, McDonald, William, Asztalos, Szilard, Pham, Thao N.D., Tonetti, Debra A., Tyner, Angela L.
Publicado 2014

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature

por Asztalos, Szilard, Pham, Thao N., Gann, Peter H., Hayes, Meghan K., Deaton, Ryan, Wiley, Elizabeth L., Emmadi, Rajyasree, Kajdacsy-Balla, Andre, Banerji, Nilanjana, McDonald, William, Khan, Seema A., Tonetti, Debra A.
Publicado 2015

G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer

por Andreano, Kaitlyn J., Wardell, Suzanne E., Baker, Jennifer G., Desautels, Taylor K., Baldi, Robert, Chao, Christina A., Heetderks, Kendall A., Bae, Yeeun, Xiong, Rui, Tonetti, Debra A., Gutgesell, Lauren M., Zhao, Jiong, Sorrentino, Jessica A., Thompson, Delita A., Bisi, John E., Strum, Jay C., Thatcher, Gregory R. J., Norris, John D.
Publicado 2020